Horizon Therapeutics is an Ireland-based biopharmaceutical company that researches and develops novel therapeutic medicines for rheumatic diseases.Read more
Horizon's revenue is the ranked 1st among it's top 10 competitors. The top 10 competitors average 613.4M. Over the last four quarters, Horizon's revenue has grown by 30.8%. Specifically, in Q2 2021's revenue was $832.5M; in Q1 2021, it was $342.4M; in Q4 2020, it was $745.3M; in Q3 2020, Horizon's revenue was $636.4M.